Trials / Completed
CompletedNCT04084847
Berberis Vulgaris Consumption and Blood Pressure
Effect of Berberis Vulgaris Consumption on Blood Pressure and Plasma Lipids in Subjects With Cardiovascular Risk Factors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Shahid Beheshti University · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the effect of barberry consumption on systolic and diastolic blood pressure, serum lipids, and inflammatory status. The study will involve cases having elevated BP (129/ \< 85) and known hypertensive patients on medical treatment. Seventy people will be randomized into two groups, including intervention (barberry) or placebo groups. Before and after of 8 week intervention, 24-hour ambulatory blood pressure monitoring will be done and fasting venous blood sample will be taken to measure plasma lipids. In addition, 24-hour urine will be collected to measure its sodium content and estimate sodium intake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | berberis vulgaris=barberry | 10 grams of barberry powder will be consumed daily for 8 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Placebo powder |
Timeline
- Start date
- 2019-09-18
- Primary completion
- 2020-08-19
- Completion
- 2020-10-21
- First posted
- 2019-09-10
- Last updated
- 2020-10-26
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT04084847. Inclusion in this directory is not an endorsement.